Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AMGN | GILD | CELG | VRTX |
| Company | Crispr Therapeutics Ag | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 54.09 | 312.89 | 64.72 | 108.01 | 420.67 |
| High | 54.89 | 314.89 | 66.20 | 108.59 | 423.32 |
| Low | 51.02 | 309.82 | 64.67 | 107.27 | 417.50 |
| Last | 51.17 | 310.15 | 65.96 | 108.24 | 422.78 |
| Change | -2.38 | -2.71 | +1.38 | +0.11 | +3.79 |
| % Change | -4.44% | -0.87% | +2.14% | +0.10% | +0.90% |
| Volume | 1,632,000 | 2,611,700 | 8,732,800 | 191,230,496 | 1,064,500 |
| 20-Day Average Volume | 1,369,790 | 2,930,855 | 7,614,355 | 16,188,930 | 1,107,775 |
| Previous Close | 53.55 | 312.86 | 64.58 | 108.13 | 418.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 55.10 | 281.61 | 65.99 | 108.17 | 401.94 |
| 20-Day Raw Stochastic | 1.51% | 79.89% | 39.52% | 63.25% | 91.71% |
| 20-Day Relative Strength | 33.07% | 65.95% | 39.82% | 64.69% | 62.31% |
| Weighted Alpha | -33.92 | +34.03 | -19.29 | +46.30 | +22.92 |
| Today's Opinion | 56% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 56% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.45% since 05/03/24 | -0.37% since 05/03/24 | +1.82% since 05/03/24 | -1.97% since 11/13/19 | +5.41% since 05/03/24 |
| Low | 51.02 on 05/10/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 107.27 on 11/20/19 | 394.03 on 05/07/24 |
| High | 57.42 on 05/06/24 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 110.53 on 11/14/19 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -17.12% since 04/10/24 | +16.40% since 04/10/24 | -3.17% since 04/10/24 | +5.14% since 10/18/19 | +6.34% since 04/10/24 |
| Low | 51.02 on 05/10/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 63.08 on 04/11/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 110.70 on 11/13/19 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -26.91% since 02/09/24 | +6.54% since 02/09/24 | -10.47% since 02/09/24 | +13.63% since 08/20/19 | -0.03% since 02/09/24 |
| Low | 51.02 on 05/10/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 91.10 on 02/22/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -3.74% since 11/10/23 | +16.03% since 11/10/23 | -13.12% since 11/10/23 | +14.14% since 05/20/19 | +13.15% since 11/10/23 |
| Low | 48.55 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,545,485 | 167,829,040 | 80,407,072 | 77,035,920 | 108,121,632 |
| Shares Outstanding, K | 84,883 | 536,435 | 1,245,077 | 711,714 | 258,053 |
| Annual Sales | 371,210,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -153,610,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 201,210,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 89,350,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.43 on 05/08/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 10.99 | 27.81 |